Final answer:
Atropine or glucopyrolate is given for ECT to prevent side effects such as excessive salivation and bradycardia. These anticholinergic drugs block acetylcholine to reduce the risk of complications during ECT.
Step-by-step explanation:
Atropine or glucopyrolate is given for electroconvulsive therapy (ECT) to prevent potential side effects.
During ECT, the patient receives a controlled electric shock to induce a seizure. This can cause excessive salivation and bradycardia, which are unwanted effects. Atropine or glucopyrolate, both anticholinergic drugs, are administered to counteract these effects.
These drugs work by blocking the actions of acetylcholine, a neurotransmitter that regulates various bodily functions including heart rate and saliva production. By blocking acetylcholine, atropine or glucopyrolate can prevent excessive salivation and slow heart rate, reducing the risk of complications during ECT.